Last reviewed · How we verify
Cordstem-ST
At a glance
| Generic name | Cordstem-ST |
|---|---|
| Sponsor | CHABiotech CO., Ltd |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Phase 1 Clinical Trial of CordSTEM-ST (PHASE1)
- Evaluation of the Safety and Potential Therapeutic Effects of Cordstem-ST in Patients With Cerebral Infarction (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Cordstem-ST CI brief — competitive landscape report
- Cordstem-ST updates RSS · CI watch RSS
- CHABiotech CO., Ltd portfolio CI